These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9052413)
1. Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodies. Mottolese M; Venturo I; Rinaldi M; Lopez M; Bigotti G; Benevolo M; Natali PG Br J Cancer; 1997; 75(4):572-8. PubMed ID: 9052413 [TBL] [Abstract][Full Text] [Related]
2. Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin. Mottolese M; Venturo I; Donnorso RP; Curcio CG; Rinaldi M; Natali PG Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1277-84. PubMed ID: 3053205 [TBL] [Abstract][Full Text] [Related]
3. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture. Mottolese M; Cianciulli A; Venturo I; Perrone Donnorso R; Salzano M; Benevolo M; Bigotti G; Natali PG Diagn Cytopathol; 1992; 8(2):153-60. PubMed ID: 1568412 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions. Lee JS; Nam JH; Lee MC; Park CS; Juhng SW Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877 [TBL] [Abstract][Full Text] [Related]
5. [Contribution of immunocytochemical marking of benign cells to the diagnosis of serous effusions]. Gaulier A; Cava E; Chosia MC; Pore G; Marsan C Ann Pathol; 1986; 6(4-5):323-8. PubMed ID: 3814272 [TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical staining with monoclonal antibodies in cytologically "negative" serous effusions from patients with malignant disease. Ghosh AK; Mason DY; Spriggs AI J Clin Pathol; 1983 Oct; 36(10):1150-3. PubMed ID: 6194182 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions. Linari A; Bussolati G J Clin Pathol; 1989 Nov; 42(11):1184-9. PubMed ID: 2685053 [TBL] [Abstract][Full Text] [Related]
8. Combinations of monoclonal antibodies can distinguish primary lung tumors from metastatic lung tumors sampled by fine needle aspiration biopsy. Mottolese M; Venturo I; Rinaldi M; Campioni N; Aluffi A; Curcio CG; Donnorso RP; Natali PG Cancer; 1989 Dec; 64(12):2493-500. PubMed ID: 2479460 [TBL] [Abstract][Full Text] [Related]
9. Malignant melanoma in fine needle aspirates and effusions. An immunocytochemical study using monoclonal antibodies. Angeli S; Koelma IA; Fleuren GJ; Van Steenis GJ Acta Cytol; 1988; 32(5):707-12. PubMed ID: 2458662 [TBL] [Abstract][Full Text] [Related]
10. Positive effusion cytology as the initial presentation of malignancy. Monte SA; Ehya H; Lang WR Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540 [TBL] [Abstract][Full Text] [Related]
11. Immunological screening for tumor cells in serous body fluids has added value with the CELL-DYN Sapphire. Keuren JF; Hoffmann JJ; Leers MP Clin Chem Lab Med; 2014 Feb; 52(2):253-8. PubMed ID: 24096441 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the expression of CEA and a myelomonocytic antigen (CD15) in serous effusions using two monoclonal antibodies NEO 723 and Leu M1]. Daste G; Berthier F; Mauduyt MA; Soleilhavoup JP Arch Anat Cytol Pathol; 1992; 40(4):183-9. PubMed ID: 1294046 [TBL] [Abstract][Full Text] [Related]
13. Reactivity of tumor cells in malignant effusions with a panel of monoclonal and polyclonal antibodies. Shaw P; Buckman R; Law J; Baumal R; Marks A Tumour Biol; 1988; 9(2-3):101-9. PubMed ID: 3041546 [TBL] [Abstract][Full Text] [Related]
14. Identification of adenocarcinoma in cytospin preparations of effusions using monoclonal antibody B72.3. Martin SE; Moshiri S; Thor A; Vilasi V; Chu EW; Schlom J Am J Clin Pathol; 1986 Jul; 86(1):10-8. PubMed ID: 3524191 [TBL] [Abstract][Full Text] [Related]
15. Applications of monoclonal antibodies in clinical cytology as exemplified by studies with monoclonal antibody B72.3. The George N. Papanicolaou award lecture. Johnston WW Acta Cytol; 1987; 31(5):537-56. PubMed ID: 3314301 [TBL] [Abstract][Full Text] [Related]
16. Immunocytochemistry in the differential diagnosis of serous effusions: a comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Lozano MD; Panizo A; Toledo GR; Sola JJ; Pardo-Mindán J Cancer; 2001 Feb; 93(1):68-72. PubMed ID: 11241268 [TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical staining of cells in pleural and peritoneal effusions with a panel of monoclonal antibodies. Ghosh AK; Spriggs AI; Taylor-Papadimitriou J; Mason DY J Clin Pathol; 1983 Oct; 36(10):1154-64. PubMed ID: 6194183 [TBL] [Abstract][Full Text] [Related]
18. Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms. Harłozińska A; Bar JK; Cisło M; Richter R; Rabczyński J Anal Cell Pathol; 1992 Jan; 4(1):1-12. PubMed ID: 1370907 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of antigens by human small cell lung carcinoma in sections of tumour and in serous effusions. Moss F; Bobrow L; Happerfield L; Souhami R; Beverley P Br J Cancer Suppl; 1991 Jun; 14():54-5. PubMed ID: 1645573 [TBL] [Abstract][Full Text] [Related]
20. Application of molecular genetics to the diagnosis of lymphoid-rich effusions: study of 95 cases with concomitant immunophenotyping. Mihaescu A; Gebhard S; Chaubert P; Rochat MC; Braunschweig R; Bosman FT; Delacrétaz F; Benhattar J Diagn Cytopathol; 2002 Aug; 27(2):90-5. PubMed ID: 12203875 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]